Bank of Montreal
BNGO icon

Bank of Montreal’s Bionano Genomics BNGO Stock Holding History

Bank of Montreal’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-93
Closed -$82.9K – 3804
2022
Q4 		$82.9K Hold
93
– – ﹤0.01% 3418
2022
Q3 		$105 Hold
93
– – ﹤0.01% 3447
2022
Q2 		$82 Hold
93
– – ﹤0.01% 3505
2022
Q1 		$151K Buy
+93
New +$126K ﹤0.01% 3553

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's BNGO Position: Q2 2023 in Review

Bank of Montreal sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 30 shares — an estimated $20.3K sold.

Bank of Montreal first reported a position in BNGO in Q3 2020 and held it in 9 quarters. The position peaked at $736K in Q4 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Bank of Montreal reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 30 Bionano Genomics shares in Q2 2023, an estimated $20.3K.
  • Bank of Montreal first reported a position in Bionano Genomics in Q3 2020 and held it in 9 quarters.
  • Bank of Montreal's Bionano Genomics position peaked at $736K in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.